Methods-Sixty five consecutive eyes (64 patients) with PVR in different stages requiring surgical intervention where liquid perfluorocarbons were used were compared with 64 consecutive eyes (62 patients) operated without the help of perfluorocarbon immediately before this time. Both groups were similar with regard to severity of PVR, number of operations, and initial visual acuity. The observation period was shorter in the perfluorocarbon group because they were operated more recently (17.4 Tables 1  and 2) .
Excluded from the study were patients who (SB) .
No attention was given to differences between perfluorodecalin and -octane; both products (Adatomed, Germany) were used periodically, showed the same ability to flatten the retina, and were easily visible.
Postoperatively the eyes were followed over a period of 11 To summarise, a 61% success rate was achieved in this group.
APPEARANCE AND SEVERITY OF REPROLIFERATION
In both groups we observed reproliferation not earlier than 1 month postoperatively. In group 1 the time of appearance ranged between 1 and 9 months after surgery with an average of months which is comparable with that in group 2 where reproliferation started 1 to 12 months postoperatively (average 3-34 months). Anterior reproliferation on the encircling band or posterior reproliferation behind it did not develop in any specific period.
However, the rate of massive, severe reproliferation followed by anterior segment complications and extremely poor visual outcome was 2-5 times higher (23% as against 9%) in eyes operated on without perfluorocarbon liquids (see Tables 4 and 5 ). We observed in our series that the use of heavy liquids improved the prognosis of eyes with postoperative reproliferation by reducing the severity.
POSTOPERATIVE COMPLICATIONS
We also investigated the benefit of intraoperative perfluorocarbon tamponades with regard to the development of secondary glaucoma and bullous or band keratopathies. Secondary glaucoma was classified as treatable when topical therapy given for several months postoperatively was sufficient to normalise the intraocular pressure, whereas in cases of untreatable glaucoma the pressure was elevated to more than 20 mm Hg in spite of local and systemic antiglaucomatous therapy.
In group 15 We agree with other authors12 15-17 that the development of reproliferating tissue occurs in the early postoperative period. In our series it appeared in a similar average time after surgery (2-87 months and 3 14 months respectively) in both groups. The longer follow up period of the patients who had surgery before the perfluorocarbons era cannot influence the reproliferation rate decisively as the minimum observation period was 10 months for all patients -a time during which 97% of the proliferations had already developed.
In accordance with previous reports'2 16 we could identify reproliferation which started with massive contraction of the anterior retina and resulted in anterior and posterior traction redetachment as the -most common cause of anatomical failure mainly in eyes operated on unsuccessfully without perfluorocarbons. In eyes with primarily reattached retina we observed the posterior retina to be the most frequent location for the development of reproliferation in both groups (about 50%).
This higher incidence of eyes that had to be abandoned in group 2 also explains the higher frequency of secondary glaucoma and keratopathy in this group. Temporary elevated pressure was measured in 26% in group 1 as against 39% in group 2. At the end offollow up chronic glaucoma was observed in 11% of the group operated on with perfluorocarbons and 20% of the group that had surgery without perfluorocarbons. The 
